TCR analysis reveals significant repertoire selection during in vitro lymphocyte culture

International Immunology

Volumn 9, Issue 8, 1997, Pages 1073-1083

  Dietrich, Pierre Yves ^a   Walker, Paul R ^a   Schnuriger, Valérie ^a   Saas, Philippe ^a   Perrin, Gaëlle ^a   Guillard, Maryvonne ^b   Gaudin, Catherine ^b   Caignard, Anne ^b  

^a Hôpital Universitaire HUG   (Switzerland)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Glioma; Renal cell carcinoma; Skewing; TCR chain; Tumor immunology

Indexed keywords

T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN;

ANTIGEN PRESENTATION; ARTICLE; CELL SPECIFICITY; CELL STIMULATION; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KIDNEY CARCINOMA; LYMPHOCYTE CULTURE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; T LYMPHOCYTE RECEPTOR GENE; T LYMPHOCYTE SUBPOPULATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL;

AMINO ACID SEQUENCE; BASE SEQUENCE; CARCINOMA, RENAL CELL; CELL CULTURE TECHNIQUES; CLONAL DELETION; GENE EXPRESSION REGULATION; GLIOBLASTOMA; IMMUNOGLOBULIN VARIABLE REGION; KIDNEY NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS;

EID: 0030742371     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.8.1073     Document Type: Article

References (56)

1. Boon, T. and Van der Bruggen, P. 1996. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183:725.
2. Alexander, J., Kudoh, S., Melsop, K., Hamilton, T., Edinger, M., Tubbs, R. R., Sica, D., Tuason, L., Klein, E., Bukowski, R. and Finke, J. 1993. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res. 53:1380.
3. + T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis. Clin. Cancer Res. 2:87.
4. + tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro. Eur. J. Immunol. 24:1966.
5. Maudsley, D. J. and Pound, J. D. 1991. Modulation of MHC antigen expression by viruses and oncogenes. Immunol. Today 12:429.
6. Dhib-Jalbut, S., Kufta, C. V., Flerlage, M., Shimojo, N. and McFarland, H. F. 1990. Adult human glial cells can present target antigens to HLA-restricted cytotoxic T-cells. J. Neuroimmunol. 29:203.
7. Luboldt, H. J., Kubens, B. S., Rübben, H. and Grosse-Wilde, H. 1996. Selective loss of human leukocyte antigen class I allele expression in advanced renal cell carcinoma. Cancer Res. 56:826.
8. Boon, T., Cerottini, J. C., Van den Eynde, B., Van der Bruggen, P. and Van Pel, A. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337.
9. Harding, C. V. and Unanue, E. R. 1990. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature 346:574.
10. Mottez, E., Langlade-Demoyen, P., Gournier, H., Martinon, F., Maryanski, J., Kourilsky, P. and Abastado, J. P. 1995. Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic. J. Exp. Med. 181:493.
11. Restifo, N. P., Esquivel, F., Kawakami, Y., Yewdell, J. W., Mule, J. J., Rosenberg, S. A. and Bennink J. R. 1993. Identification of human cancers deficient in antigen processing. J. Exp. Med. 177:265.
12. Cochet, M., Pannetier, C., Regnault, A., Darche, S., Leclerc, C. and Kourilsky, P. 1992. Molecular detection and in vivo analysis of the specific T cell response to a protein antigen. Eur. J. Immunol. 22:2639.
13. Pannetier, C., Even, J. and Kourilsky, P. 1995. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today 16:176.
14. Levraud, J. P., Pannetier, C., Langlade-Demoyen, P., Brichard, V. and Kourilsky, P. 1996. Recurrent T cell receptor rearrangements in the cytotoxic T lymphocyte response in vivo against the P815 murine tumor. J. Exp. Med. 183:439.
15. Caignard, A., Guillard, M., Gaudin, C., Escudier, B., Triebel, F. and Dietrich, P. Y. 1996. In situ demonstration of renal cell carcinoma specific T-cell clones. Int. J. Cancer 66:564.
16. Walker, P. R., Ohteki, T., Lopez, J. A., MacDonald, H. R. and Maryanski, J. L. 1995. Distinct phenotypes of antigen-selected CD8 T cells emerge at different stages of an in vivo immune response. J. Immunol. 155:3443.
17. Hercend, T., Reinherz, E. L., Meuer, S., Schlossman, S. F. and Ritz, J. 1983. Phenotypic and functional heterogeneity of human cloned natural killer cell lines. Nature 301:158.
18. Genevee, C., Diu, A., Nierat, J., Caignard, A., Dietrich, P. Y., Ferradini, L., Roman-Roman, S., Triebel, F. and Hercend, T. 1992. An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur. J. Immunol. 22:1261.
19. Genevee, C., Dietrich, P. Y., Robache, S., Guillard, M., Escudier, B., Terrier-Lacombe, M. J., Triebel, F. and Caignard, A. 1995. In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma. Cancer Res. 55:685.
20. Farace, F., Angevin, E., Escudier, B., Caignard, A., Dietrich, P. Y., Genevee, C., Hercend, T. and Triebel, F. 1993. Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinoma. Int. J. Cancer 54:741.
21. Even, J., Lim, A., Puisieux, I., Ferradini, L., Dietrich, P. Y., Toubert, A., Hercend, T., Triebel, F., Pannetier, C. and Kourilsky, P. 1995. T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor beta-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseases. Res. Immunol. 146:65.
22. Ebato, M., Nitta, T., Yagita, H., Sato, K. and Okumura, K. 1994. Shared amino acid sequences in the NDbetaN and Nalpha regions of the T cell receptors of tumor-infiltrating lymphocytes within malignant glioma. Eur. J. Immunol. 24:2987.
23. Moretta, A., Pantaleo, G., Moretta, L., Cerottini, J. C. and Mingari, M. C. 1983. Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity. J. Exp. Med. 157:743.
24. Miescher, S., Whiteside, T. L., de Tribolet, N. and Von Fliedner, V 1988. In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers. J. Neurosurg. 68:438.
25. Farace, F., Orlanducci, F., Dietrich, P. Y., Gaudin, C., Angevin, E., Courtier, M. H., Bayle, C., Hercend, T. and Triebel, F. 1994. T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions. J. Immunol. 153:4281.
26. Mackensen, A., Ferradini, L., Carcelain, G., Triebel, F., Faure, F., Viel, S. and Hercend, T. 1993. Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res. 53:3569.
27. Mackensen, A., Carcelain, G., Viel, S., Raynal, M. C., Michalaki, H., Triebel, F., Bosq, J. and Hercend, T. 1994. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. Clin. Invest. 93:1397.
28. Fontana, A., Hengartner, H., de Tribolet, N. and Weber, E. 1984. Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J. Immunol. 132:1837.
29. Huber, D., Philipp, J. and Fontana, A. 1992. Protease inhibitors interfere with the transforming growth factor-β-dependent but not the transforming growth factor-β-independent pathway of tumor cell-mediated immunosuppression. J. Immunol. 148:277.
30. Hishii, M., Nitta, T., Ishida, H., Ebato, M., Kurosu, A., Yagita, H., Sato, K. and Okumura, K. 1995. Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro. Neurosurgery 37:1160.
31. + T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells. Cell. Immunol. 150:114.
32. Nakagomi, H., Pisa, P., Pisa, E. K., Yamamoto, Y., Halapi, E., Backlin, K., Juhlin, C. and Kiessling, R. 1995. Lack of Interleukin-2 (IL-2) expression and selective expression of IL-10mRNA in human renal cell carcinoma. Int. J. Cancer 63:366.
33. Wang, Q., Radovan, C., Tubbs, R., Olencki, T., Klein, E., Kudoh, S., Finke, J. and Bukowski, R. M. 1995. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes. Int. J. Cancer 61:780.
34. Maeurer, M. J., Martin, D. M., Castelli, C., Elder, E., Leder, G., Storkus, W. J. and Lotze, M. T. 1995. Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes. Cancer Immunol. Immunother. 41:111.
35. Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L., Schneider, P., Bornand, T., Fontana, A., Lienard, D., Cerottini, J.-C. and Tschopp, J. 1996. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 274:1363.
36. O'Connell, J., O'Sullivan, G. C., Collins, J. K. and Shanahan, F. 1996. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 184:1075.
37. Strand, S., Hofmann, W. J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H. and Galle, P. R. 1996. Lymphocyte apoptosis induced by CD95 (Apo-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nature Medicine 2:1361.
38. Saas, P., Walker, P. R., Hahne, M., Quiquerez, A.-L., Schnuriger, V., Perrin, G., French, L., Van Meir, E. G., de Tribolet, N., Tschopp, J. and Dietrich, P. Y. 1997. Fas Ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J. Clin. Invest. 99:1173.
39. June, C. H., Bluestone, J. A., Nadler, L. M. and Thompson, C. B. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
40. Leach, D. R., Krummel, M. F. and Allison, J. P. 1996. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734.
41. Van Parijs, L., Ibraghimov, A. and Abbas, A. K. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.
42. Sloan-Lancaster, J., Shaw, A. S., Rothbard, J. B. and Allen, P. M. 1994. Partial T cell signaling: altered phospho-zeta and lack of ZAP-70 recruitment in APL-induced T cell anergy. Cell 79:913.
43. Klenerman, P., Rowland-Jones, S., McAdam, S., Edwards, J., Daenke, S., Lalloo, D., Koppe, B., Rosenberg, W., Boyd, D., Edwards, A., Giangrande, P., Phillips, R. E. and McMichael, A. J. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 gag variants. Nature 369:403.
44. Bertoletti, A., Sette, A., Chisari, F. V., Penna, A., Levrero, M., De Carli, M., Fiaccadori, F. and Ferrari, C. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407.
45. Madrenas, J., Wange, R. L., Wang, J. L., Isakov, N., Samelson, L. E. and Germain, R. N. 1995. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267:515.
46. Caignard, A., Dietrich, P. Y., Morand, V., Lim, A., Pannetier, C., Leridant, A. M., Hercend, T., Even, J., Kourilsky, P. and Triebel, F. 1994. Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neck. Cancer Res. 54:1292.
47. d binding peptides and induction of peptide specific CTL. J. Immunol. Methods 176:245.
48. Liu, B., Podack, E. R., Allison, J. P. and Malek, T. R. 1996. Generation of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumors. J. Immunol. 156:1117.
49. Yang, G., Hellstrom, K. E., Mizuno, M. T. and Chen, L. 1995. In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation. J. Immunol. 155:3897.
50. Gajewski, T. F , Renauld, J. C., Van Pel, A. and Boon, T. 1995 Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro. J. Immunol. 154:5637.
51. + T cells in lymph node and lung of mice with Sendai virus pneumonia by LECAM-1 and CD45RB phenotype. J. Immunol. 150:5494
52. Mobley, J. L., Rigby, S. M. and Dailey, M. O. 1994. Regulation of adhesion molecule expression by CD8 T cells in vivo. II. Expression of L-selectin (CD62L) by memory cytolytic T cells responding to minor histocompatibility antigens. J. Immunol. 153:5443.
53. Razvi, E. S., Welsh, R. M. and McFarland, H. I. 1995. In vivo state of antiviral CTL precursors. Characterization of a cycling cell population containing CTL precursors in immune mice. J. Immunol. 154:620.
54. Marchand, M., Weynants, P., Rankin, E., Arienti, F., Belli, F., Parmiani, G., Cascinelli, N., Bourlond, A., Vanwijck, R., Humblet, Y., Canon, J.-L., Laurent, C., Naeyaert, J.-M., Plagne, R., Deraemaeker, R., Knuth, A., Jäger, E., Brasseur, F., Herman, J., Coulie, P. G. and Boon, T. 1995. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer 63:883.
55. Arden, B., Clark, S. P., Kabelitz, D. and Mak, T. W. 1995. Human T-cell receptor variable gene segment families. Immunogenetics 42:455.
56. Chothia, C., Boswell, D. R. and Lesk, A. M. 1988. The outline structure of the T-cell alpha beta receptor. EMBO J. 7:3745.